Literature DB >> 79632

Endogenous steroid levels in the human prostate from birth to old age: a comparison of normal and diseased tissues.

G L Hammond.   

Abstract

The levels of steroids in prostatic tissues were determined by radioimmunoassay after solvent extraction of a single (300--600 mg wet tissue) sample and chromatography of extracts on hydroxyalkoxypropyl Sephandex microcolumns. In normal adult prostates (n = 18) the concentrations of steroids (mean +/- S.E.M. ng/g wet tissue) were: testosterone, 0.25 +/- 0.04; androstenedione, 0.13 +/- 0.03; 5alpha-androstane-3,17-dione (5alpha-androstanedione), 1.31 +/- 0.30; 17beta-hydroxy-5alpha-androstan-3-one (5alpha-dihydrotestosterone, DHT), 1.22 +/- 0.14; 5alpha-androstane-3alpha, 17 beta-diol (3alpha-androstanediol), 4.32 +/- 0.49; androsterone, 4.15 +/- 1.07; progestrone, 0.39 +/- 0.07; 17alpha-hydroxyprogestrone, 0.42 +/- 0.06. Concentrations of of steroids tissues from outer-gland regions were within the ranges found in the periurethral regions. In the prostates of newborn boys, the concentrations of all steroids were high, including progesterone and 17alpha-hydroxyprogesterone. Apart from 3alpha-androstanediol, the levels of which tend to increase after this age, the concentrations of all steroids were lower in the infant and pubertal prostates, but most were re-established to a variable extend in the adult tissues. This was particularly evident with respect to 5alpha-androstanedione and androsterone, and it is suggested that these two androgens may have a functional role in the mature prostate. The concentrations of testosterone, androstenedione, 5alpha-androstanedione, progesterone and 17alpha-hydroxyprogesterone in tissue taken from ten patients with benign prostatic hypertrophy (BPH) were similar to those in normal adult adult tissue. The concentration of DHT was markedly raised (5.33 +/- 0.46 ng/g) and the level of 3alpha-androstanediol and androsterone were reduced (1.40 +/- 0.12 ng/g respectively) in adenomatous compared with normal tissue. The concentrations of various androgens displayed remarkable interelationships which characterize normal and BPH tissues. The concentrations of testosterone, androstenedione, DHT and 3alpha-androstanediol were particularly high in the untreated prostatic carcinomatous tissue sample investigated, whereas the concentrations of 5alpha-androstanedione and androsterone were very low. After oestrogen treatment, testosterone and androstenedione virtually disappeared, while reduced but significant concentrations of their metabolites remained in similar proportions to those observed in the untreated carcinomatous tissue. Under the conditions of therapy, oestrogens are suggested to influence the uptake of androgens.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 79632     DOI: 10.1677/joe.0.0780007

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  10 in total

Review 1.  Is exercise beneficial in the prevention of prostate cancer?

Authors:  S A Oliveria; I M Lee
Journal:  Sports Med       Date:  1997-05       Impact factor: 11.136

Review 2.  PPARγ: a molecular link between systemic metabolic disease and benign prostate hyperplasia.

Authors:  Ming Jiang; Douglas W Strand; Omar E Franco; Peter E Clark; Simon W Hayward
Journal:  Differentiation       Date:  2011-06-08       Impact factor: 3.880

3.  A double-blind trial of an extract of the plant Serenoa repens in benign prostatic hyperplasia.

Authors:  G Champault; J C Patel; A M Bonnard
Journal:  Br J Clin Pharmacol       Date:  1984-09       Impact factor: 4.335

Review 4.  Androgen action in prostate function and disease.

Authors:  Partha P Banerjee; Subhadra Banerjee; Terry R Brown; Barry R Zirkin
Journal:  Am J Clin Exp Urol       Date:  2018-04-01

Review 5.  Role of prostate stem cells and treatment strategies in benign prostate hyperplasia.

Authors:  Kalyan J Gangavarapu; Peter F Jowdy; Barbara A Foster; Wendy J Huss
Journal:  Am J Clin Exp Urol       Date:  2022-06-15

Review 6.  An overview of benign prostatic hyperplasia and its appreciation in Greco-Arab (Unani) system of medicine.

Authors:  Shabir Ahmad Bhat; Shameem Ahmad Rather; Naquibul Islam
Journal:  Asian J Urol       Date:  2021-05-29

7.  Androgens transduce the G alphas-mediated activation of protein kinase A in prostate cells.

Authors:  Gargi Bagchi; Juanjuan Wu; John French; Jae Kim; Nader H Moniri; Yehia Daaka
Journal:  Cancer Res       Date:  2008-05-01       Impact factor: 12.701

8.  Tissue content of dihydrotestosterone in human prostatic hyperplasis is not supranormal.

Authors:  P C Walsh; G M Hutchins; L L Ewing
Journal:  J Clin Invest       Date:  1983-11       Impact factor: 14.808

9.  Spontaneous benign prostatic hyperplasia in the beagle. Age-associated changes in serum hormone levels, and the morphology and secretory function of the canine prostate.

Authors:  C B Brendler; S J Berry; L L Ewing; A R McCullough; R C Cochran; J D Strandberg; B R Zirkin; D S Coffey; L G Wheaton; M L Hiler; M J Bordy; G D Niswender; W W Scott; P C Walsh
Journal:  J Clin Invest       Date:  1983-05       Impact factor: 14.808

10.  Upregulation of Phosphodiesterase type 5 in the Hyperplastic Prostate.

Authors:  Wenhao Zhang; Ning Zang; Yaoming Jiang; Ping Chen; Xinghuan Wang; Xinhua Zhang
Journal:  Sci Rep       Date:  2015-12-10       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.